Background: An international consensus has been reached regarding diagnostic criteria for papilloma of the urinary bladder. However, the incidences of recurrence and progression in patients with urothelial papilloma are uncertain.
Methods: The population for this study consisted of 52 patients who were diagnosed with urothelial papilloma of the bladder at the Mayo Clinic between 1914 and 1998. All histologic slides were reviewed and fulfilled the diagnostic criteria of urothelial papilloma from the 1998 World Health Organization/International Society of Urological Pathology classification system. No patients had previous or coexistent urothelial carcinoma, and none were treated after biopsy.
Results: The mean patient age at diagnosis was 57 years (range, 22-89 years). The male-to-female ratio was 1.9:1. The mean follow-up was 9.8 years (range, 0.1-58 years). Four patients developed recurrent papilloma (mean interval from diagnosis to recurrence, 3.3 years); 1 other patient developed papillary neoplasm of low malignant potential (Ta WHO Grade 1 papillary urothelial carcinoma) 6 years after the initial diagnosis of papilloma. None of these patients developed dysplasia, carcinoma in situ, or invasive urothelial carcinoma or died of bladder cancer.
Conclusions: Patients with urothelial papilloma have a low incidence of recurrence and rarely, if ever, develop urothelial carcinoma.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
KRT18 as a Novel Biomarker of Urothelial Papilloma while Evaluating Low-Grade Papillary Urothelial Neoplasms: Bi-Center Analysis.
Pathobiology
August 2024
Department of Pathology, Seoul National University Hospital, Seoul, Republic of Korea.
Article Synopsis
- * A proteomic analysis of 31 papillary urothelial lesions uncovered overlapping protein profiles for UP and PUC, with KRT18 identified as a potential diagnostic marker for UP.
- * The study suggests that KRT18 could help differentiate UP from low-grade PUC, and also noted that some patients with UP may develop urothelial carcinoma later, indicating a risk for malignancy.
Quantitative proteomics and immunohistochemistry uncover NT5DC2 as a diagnostic biomarker for papillary urothelial carcinoma.
Heliyon
August 2024
Seoul National University College of Medicine, Seoul, 03080, Republic of Korea.
The accurate diagnosis of papillary urothelial carcinoma (PUC) is frequently challenging due to benign mimickers. Other than morphology-based diagnostic criteria, reliable biomarkers for differentiating benign and malignant papillary urothelial neoplasms remain elusive, so we sought to discover new markers to address this challenge. We first performed tandem mass spectrometry-based quantitative proteomics using diverse papillary urothelial lesions, including PUC, urothelial papilloma (UP), inverted urothelial papilloma, and cystitis cystica.
View Article and Find Full Text PDFThe Feasibility and Diagnostic Adequacy of PD-L1 Expression Analysis Using the Cytoinclusion Technique in Bladder Cancer: A Prospective Single-Center Study.
J Clin Med
July 2024
Department of Urology, Veneto Institute of Oncology (IOV)-IRCCS, Headquarter of Castelfranco Veneto, 35128 Padua, Italy.
Article Synopsis
- - The study investigates the role of PD-L1 expression as a potential biomarker for bladder cancer by analyzing its presence in urine samples from patients undergoing surgical treatment for the disease.
- - Among 29 patients, PD-L1 expression rates varied significantly across tumor grades, with higher detection in high-grade tumors and good agreement between urine tests (cytoinclusion) and traditional tissue analysis (histopathology).
- - The research suggests cytoinclusion can serve as a promising, non-invasive method for assessing PD-L1 levels, potentially aiding in the diagnosis and prognosis of bladder cancer, and recommends further standardization for clinical use.
Bladder papilloma: A rare benign tumor - Case report and literature review.
Int J Surg Case Rep
July 2024
Department of Urology, Mohamed VI University Hospital, Oujda, Morocco.
Article Synopsis
- * A case study involved a 66-year-old male experiencing hematuria, diagnosed with bladder papilloma after imaging and cystoscopy revealed an echogenic lesion, which was confirmed to be benign post-surgery.
- * Understanding bladder papilloma's symptoms, diagnosis, and management strategies is crucial, especially since it typically appears in younger patients and presents a low risk for recurrence or progression to aggressive cancer.
Associated Pulmonary and Urogenital Disease and Pathology in a Colony of Enzootically Infected Il12rb2 Deficient and Stat1 Knockout Mice.
Comp Med
April 2024
Tri-Institutional Training Program in Laboratory Animal Medicine and Science, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, and The Rockefeller University, New York, New York; Center of Comparative Medicine and Pathology, Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine, New York, New York;, Email:
Article Synopsis
- Researchers rediscovered the intracellular bacterium Cm, historically linked to severe pneumonia in mice, in research mouse colonies, noting its moderate prevalence.
- They observed clinical disease in genetically engineered mouse strains with impaired immune responses, presenting symptoms like poor condition and hunched posture, along with histopathological evidence of Cm in various tissues.
- The study suggests that Cm could negatively impact research validity, underscoring the need to exclude this bacterium from mouse colonies used in scientific studies.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!